ATC level 3
M05BBone disease treatments, subgroup M05B
- Molecules
- 13
- Subgroups
- 4
ATC M05B (Bone disease treatments, subgroup M05B) is a level 3 group in the anatomical therapeutic chemical classification. The catalogue lists 13 molecules in it, each with brands, manufacturers and supply from India.
ATC codes are used as identifiers. Class names are written by MedsAcross and are not the WHO Collaborating Centre's text.
Subgroups
Molecules
Molecules with an ATC code under M05B.
- Alendronate and CholecalciferolBisphosphonate2 presentations1 brandM05BB03
- Alendronic acid and Cholecalciferol3 brandsM05BB03
- BurosumabOrphan3 presentations2 brandsM05BX05
- DenosumabOrphanRANK Ligand Inhibitor21 presentations48 brandsM05BX04
- Dibotermin alfa1 brandM05BC01
- IbandronateBisphosphonate2 presentationsM05BA06
- Ibandronic acid5 brandsM05BA06
- PamidronateBisphosphonate3 presentationsM05BA03
- RisedronateBisphosphonate5 presentationsM05BA07
- RomosozumabBiologic1 presentation2 brandsM05BX06
- VosoritideOrphan3 presentations4 brandsM05BX
- VysribliBiologic1 brandM05BX04
- Zoledronic acidOrphanBisphosphonate4 presentations6 brandsM05BA08
For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Cannot find the medicine you need?
Our sourcing team can find unlisted, unapproved and hard-to-find medicines through licensed channels.